A detailed history of Bank Of America Corp transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 628 shares of BOLT stock, worth $389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
628
Previous 628 -0.0%
Holding current value
$389
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.27 - $1.95 $14,163 - $21,746
-11,152 Reduced 94.67%
628 $0
Q1 2023

May 12, 2023

BUY
$1.29 - $1.66 $14,166 - $18,230
10,982 Added 1376.19%
11,780 $16,000
Q3 2022

Nov 14, 2022

SELL
$1.48 - $2.61 $7,737 - $13,645
-5,228 Reduced 86.76%
798 $1,000
Q2 2022

Aug 12, 2022

SELL
$1.41 - $2.91 $6,718 - $13,866
-4,765 Reduced 44.16%
6,026 $12,000
Q1 2022

May 16, 2022

SELL
$2.74 - $4.82 $131,851 - $231,943
-48,121 Reduced 81.68%
10,791 $29,000
Q4 2021

Feb 08, 2022

BUY
$4.19 - $13.97 $160,037 - $533,584
38,195 Added 184.37%
58,912 $288,000
Q3 2021

Nov 15, 2021

BUY
$11.15 - $18.6 $116,082 - $193,644
10,411 Added 101.02%
20,717 $262,000
Q2 2021

Sep 13, 2021

BUY
$15.4 - $31.46 $158,712 - $324,226
10,306 New
10,306 $160,000

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $23.3M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.